Related Experiment Video
Updated: May 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
PRECISE-DAPT, ARC-HBR, or Simplified Clinical Evaluation for the Prediction of Major Bleeding After Percutaneous
Alexander Felix Marschall1, Juan Duarte Torres2, Belén Biscotti Rodíl2
1Department of Cardiology, Central Defense Hospital Gómez Ulla, Madrid, Spain; University of Alcalá, Madrid, Spain.
Insights
Existing bleeding risk scores like PRECISE-DAPT and ARC-HBR are not validated for older adults. A simplified clinical evaluation (SCE) using three variables showed superior predictive value for postdischarge bleeding in this population.
Area of Science:
- Cardiology
- Geriatrics
- Clinical Risk Stratification
Background:
- Older patients are underrepresented in bleeding risk studies.
- Existing scores (PRECISE-DAPT, ARC-HBR) lack validation in elderly populations undergoing percutaneous coronary intervention (PCI).
Purpose of the Study:
- To evaluate the PRECISE-DAPT and Academic Research Consortium for High Bleeding Risk (ARC-HBR) scores in patients aged ≥75 years.
- To assess the prognostic value of a simplified clinical evaluation (SCE) for postdischarge bleeding in this cohort.
Main Methods:
- Retrospective analysis of a prospective, single-center registry of patients ≥75 years undergoing PCI.
- Inclusion of 693 patients with 12-month follow-up for postdischarge bleeding events (BARC 3 or 5).
- Comparison of PRECISE-DAPT, ARC-HBR, and SCE using Cox regression and ROC analysis.
Main Results:
- PRECISE-DAPT and ARC-HBR scores did not significantly predict postdischarge bleeding (HR 1.65 and 1.46, respectively).
- The simplified clinical evaluation (SCE) demonstrated superior predictive value (HR 2.47) compared to both scores.
- All scores showed moderate discriminatory potential (AUCs ~0.60-0.62), but SCE had better reclassification improvements.
Conclusions:
- PRECISE-DAPT and ARC-HBR scores have insufficient predictive value for bleeding complications in older adults.
- A simplified clinical evaluation (SCE) using three accessible variables offers comparable or superior risk stratification in this population.
- SCE is a promising tool for bleeding risk assessment in elderly patients, warranting further validation in larger studies.
Abstract:
Older patients have been remarkably underrepresented in bleeding risk cohorts. Thus, the PRECISE-DAPT (Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy) and Academic Research Consortium for High Bleeding Risk (ARC-HBR) scores are not validated in older adults. Therefore, we sought to evaluate the PRECISE-DAPT and ARC-HBR scores in an exclusively older population and assess the prognostic value of a truly simplified clinical evaluation (SCE), consisting of only 3 binary clinical variables (hemoglobin <11 g/100 ml, previous bleeding, and anticipated use of anticoagulants). This is a retrospective analysis of the prospective single-center older-HCD registry. Consecutive patients aged ≥75 years who underwent percutaneous coronary intervention from 2012 to 2019 were included. The primary end point was postdischarge bleeding at 12 months of follow-up, defined according to the Bleeding Academic Research Consortium 3 or 5 criteria. A total of 693 patients with a mean age of 81 (±4.4) years were included in the study and 60 patients (6.8%) met the primary end point. The PRECISE-DAPT and ARC-HBR scores did not significantly predict postdischarge bleeding in the Cox regression models (hazard ratio 1.65 [0.78 to 3.42] and 1.46 [0.72 to 4.24], respectively), whereas the SCE outperformed both scores (hazard ratio 2.47, 1.34 to 4.49). All 3 scores exhibited a moderate discriminatory potential, as determined by a receiver-operating characteristic curve analysis (areas under the curve 0.601, 0.621, and 0.616, respectively), with no significant differences between them. The SCE showed an Integrated Discrimination Improvement of 0.25, p = 0.02 (SCE vs ARC-HBR) and 0.24, p = 0.01 (SCE vs PRECISE-DAPT), with an Net Reclassification Improvement of 6.54%, p = 0.37 and 7.12%, p = 0.43, respectively. In conclusion, the PRECISE-DAPT score and ARC-HBR criteria showed insufficient predictive value in older adults. A truly SCE consisting of 3 easily accessible variables not only provides equal discriminatory potential but also demonstrates superior predictive value, as determined by Cox regression models. This makes it a highly appealing tool for risk stratification, pending its evaluation in larger prospective studies.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation